title: Disseminated Mycobacterium ulcerans disease in an HIV-positive patient: a case study.
authors.forename: R Christian
authors.initials: RC
authors.lastname: Johnson
authors.forename: David
authors.initials: D
authors.lastname: Ifebe
authors.forename: Aristote
authors.initials: A
authors.lastname: Hans-Moevi
authors.forename: Luc
authors.initials: L
authors.lastname: Kestens
authors.forename: Raoul
authors.initials: R
authors.lastname: Houessou
authors.forename: Augustin
authors.initials: A
authors.lastname: Guédénon
authors.forename: Wayne M
authors.initials: WM
authors.lastname: Meyers
authors.forename: Françoise
authors.initials: F
authors.lastname: Portaels
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications* / Q000188:drug therapy; D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017291:Clarithromycin / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009165:Mycobacterium Infections, Nontuberculous / Q000150:complications* / Q000188:drug therapy; D019911:Mycobacterium ulcerans / Q000302:isolation & purification*; D016133:Polymerase Chain Reaction; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000995:Antitubercular Agents; D004977:Ethambutol; D017291:Clarithromycin; D012293:Rifampin